First Time Loading...

Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 154.69 USD -0.47% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
Johnson & Johnson?
Write Note

Wall Street
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 175.39 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

Lowest
Price Target
156.55 USD
1% Upside
Average
Price Target
175.39 USD
13% Upside
Highest
Price Target
225.75 USD
46% Upside

JNJ Last Price Targets
Johnson & Johnson

The latest public price target was made on Jul 17, 2024 by Rick Wise from Stifel Nicolaus , who expects JNJ stock to rise by 3% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Rick Wise
Stifel Nicolaus
160 USD
Upside 3%
4 days ago
Jul 17, 2024
Johnson & Johnson price target raised to $160 from $155 at Stifel
TheFly
Chris Shibutani
Goldman Sachs
160 USD
Upside 3%
1 month ago
May 30, 2024
Goldman Sachs Reinstates Johnson & Johnson (JNJ) at Neutral
StreetInsider
Chris Shibutani
Johnson Rice
160 USD
Upside 3%
1 month ago
May 30, 2024
Johnson & Johnson reinstated with a Neutral at Goldman Sachs
TheFly
Danielle Antalffy
UBS
180 USD
Upside 16%
1 month ago
May 22, 2024
UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
StreetInsider
Morten Herholdt
Johnson Rice
170 USD
Upside 10%
3 months ago
Apr 18, 2024
HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
StreetInsider
Shagun Singh
RBC Capital
175 USD
Upside 13%
3 months ago
Apr 17, 2024
Johnson & Johnson (JNJ) PT Lowered to $175 at RBC Capital
StreetInsider
Louise Chen
Johnson Rice
215 USD
Upside 39%
3 months ago
Apr 17, 2024
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Benzinga
Rick Wise
Stifel Nicolaus
155 USD
Upside 0%
3 months ago
Apr 16, 2024
Johnson & Johnson (JNJ) PT Lowered to $155 at Stifel
StreetInsider
Terence Flynn
Morgan Stanley
169 USD
Upside 9%
3 months ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Jayson Bedford
Raymond James
175 USD
Upside 13%
3 months ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Jayson Bedford
Raymond James
110 USD
Downside 29%
6 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Larry Biegelsen
Wells Fargo
163 USD
Upside 5%
6 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Shagun Singh
Johnson Rice
178 USD
Upside 15%
9 months ago
Oct 5, 2023
Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst
Benzinga
Trung Huynh
Johnson Rice
175 USD
Upside 13%
1 year ago
Jul 21, 2023
Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance
Benzinga
John Ransom
Raymond James
90 USD
Downside 42%
1 year ago
May 24, 2023
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
Show More Price Targets
Show Less Price Targets
Rick Wise
Stifel Nicolaus
Price Target 160 USD
Upside/Downside 3%
View Source
Chris Shibutani
Goldman Sachs
Price Target 160 USD
Upside/Downside 3%
View Source
Chris Shibutani
Johnson Rice
Price Target 160 USD
Upside/Downside 3%
View Source
Danielle Antalffy
UBS
Price Target 180 USD
Upside/Downside 16%
View Source
Morten Herholdt
Johnson Rice
Price Target 170 USD
Upside/Downside 10%
View Source
Shagun Singh
RBC Capital
Price Target 175 USD
Upside/Downside 13%
View Source
Louise Chen
Johnson Rice
Price Target 215 USD
Upside/Downside 39%
View Source
Rick Wise
Stifel Nicolaus
Price Target 155 USD
Upside/Downside 0%
View Source
Terence Flynn
Morgan Stanley
Price Target 169 USD
Upside/Downside 9%
View Source
Jayson Bedford
Raymond James
Price Target 175 USD
Upside/Downside 13%
View Source
Jayson Bedford
Raymond James
Price Target 110 USD
Upside/Downside 29%
View Source
Larry Biegelsen
Wells Fargo
Price Target 163 USD
Upside/Downside 5%
View Source
Shagun Singh
Johnson Rice
Price Target 178 USD
Upside/Downside 15%
View Source
Trung Huynh
Johnson Rice
Price Target 175 USD
Upside/Downside 13%
View Source
John Ransom
Raymond James
Price Target 90 USD
Upside/Downside 42%
View Source
Show More Price Targets
Show Less Price Targets
Johnson & Johnson Competitors:
Price Targets
4569
Kyorin Holdings Inc
13% Downside
CIPLA
Cipla Ltd
0% Downside
TER
Terrascend Corp
19% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
37% Upside
CONCORDBIO
Concord Biotech Ltd
5% Downside
IDT
IDT Australia Ltd
38% Downside

Revenue
Forecast

Revenue Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

2%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Net Income
Forecast

Net Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -7%.

11%
Past Growth
-7%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JNJ's stock price target?
Price Target
175.39 USD

According to Wall Street analysts, the average 1-year price target for JNJ is 175.39 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

What is Johnson & Johnson's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

What is Johnson & Johnson's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

What is Johnson & Johnson's Net Income forecast?
Projected CAGR
-7%

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -7%.